Connect with us

Technology

Hyperscale Data Provides Update on Progress of Michigan AI Data Center; More Than $70 Million Invested in Alliance Cloud Services and the Michigan Facility

Published

on

Operations under Previously Announced MSA Expected to Begin in November 2026

LAS VEGAS, Sept. 17, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), provided an update on the continued development of its Michigan AI data center (the “Michigan Facility”) operated by Alliance Cloud Services, LLC, an indirect wholly owned subsidiary of the Company (“ACS”).

As of September 15, 2026, Hyperscale Data has invested more than $70 million into ACS and the development of the Michigan Facility. This investment represents a substantial portion of the overall capital program required to prepare the Michigan Facility for the deployment of AI compute capacity to ACS’ customer, a California-based neocloud provider, pursuant to the previously announced master services agreement between such provider and ACS (“MSA”).

As part of this investment and development program, the Company has acquired a substantial amount of the equipment required to bring the contracted capacity online at the Michigan Facility. Hyperscale Data is currently working toward commencing operations under the MSA in November 2026, at which point the Company expects to begin generating revenue and cash flow from the MSA.

The MSA provides for an initial 20 megawatts (“MW”) of critical AI compute capacity and has an initial 10-year term with two five-year extension options. If the MSA continues for the entire 20-year term, the Company expects it to generate more than approximately $1.2 billion in revenue.

Additionally, the customer has the right to increase critical AI compute capacity up to a total of 52 MW, which, if fully exercised and maintained for the entire 20-year term, is expected to increase total contract revenue to more than $3.0 billion.

52 MW of critical AI compute capacity deployment would represent less than 20% of the Michigan Facility’s approximately 340 MW total potential capacity. Even following a full 52 MW deployment by the existing customer, approximately 270 MW of potential additional capacity would remain for future development and additional customer deployments, subject to obtaining the required power, infrastructure, financing and regulatory approvals.

“Our investment of more than $70 million in ACS and the Michigan campus is about execution,” stated Will Horne, Chief Executive Officer of Hyperscale Data. “This capital is part of the overall investment required to prepare the facility for our neocloud customer under the MSA, and we have now acquired a substantial amount of the equipment required for the planned deployment. We are working toward bringing the initial contracted capacity online beginning in November, when we expect to start generating revenue and cash flow under an agreement that could generate more than $3.0 billion in revenue over a 20-year term.”

“We believe the more than $70 million invested to date has created a substantial foundation for this transformation,” continued Mr. Horne. “Our immediate priority is getting our customer online, generating cash flow and successfully executing the initial deployment. From there, we intend to continue developing the campus and pursuing the significant amount of potential capacity that remains.”

The Company continues to evaluate the optimal long-term strategy for ACS and the Michigan Facility, including continued development, strategic partnerships, additional customer deployments, a potential separation or initial public offering of ACS, or a potential sale of the Michigan Facility if the Company believes such a transaction would maximize stockholder value.

Hyperscale Data expects to provide additional updates as material developments and deployment milestones are achieved.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data’s wholly owned subsidiaries, Ault Capital Group, Inc. (“ACG”), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-provides-update-on-progress-of-michigan-ai-data-center-more-than-70-million-invested-in-alliance-cloud-services-and-the-michigan-facility-302881334.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

Edsby Adopted by Three New Ontario School Districts, Expanding its Footprint to 25% of the Province

Published

on

By

The Rainbow District School Board, Conseil scolaire catholique des Aurores boréales, and Rainy River District School Board are now live with Edsby this academic year, joining the growing list of Ontario districts using the Edsby K-12 digital platform.

RICHMOND HILL, ON, Sept. 17, 2026 /CNW/ — Edsby®, a multi-award-winning, next-generation K-12 digital learning platform, is being introduced this school year in three additional Ontario school districts, bringing the total number of Ontario districts using Edsby to 18 of Ontario’s 72 school districts.

Among the new adoptions is the Rainbow District School Board (RDSB), the largest public school board in Northern Ontario. Covering a vast geographic area of 14,757 square kilometers across the regions of Sudbury, Espanola, and Manitoulin Island, RDSB supports more than 14,000 students across 29 elementary and 9 secondary schools.

“We welcome the opportunity to integrate modern technology to further support parental involvement and student achievement,” said Bruce Bourget, Chief Executive Officer of the Rainbow District School Board. “Edsby will enhance communications between the school and the home by streamlining attendance, improving safe arrival practices, providing another venue for sharing information, and celebrating student learning.”

Joining RDSB in introducing Edsby to modernize its family engagement are two more school boards in the province:

Conseil scolaire catholique des Aurores boréales (CSDCAB): Serving French-language Catholic students in Northwestern Ontario, CSDCAB will leverage Edsby to seamlessly connect its nine elementary schools, one secondary school, and remote communities in a secure, bilingual environment.Rainy River District School Board (RRDSB): A previous Edsby district, Rainy River returned to the Edsby family this year, recognizing the value of this powerful tool.

Edsby continues momentum in Ontario

The addition of RDSB, CSDCAB, and RRDSB adds to Edsby’s significant usage across the province of Ontario. Edsby is specifically designed to meet the unique and challenging needs of K-12, unlike other corporate or higher-education platforms, and has become central to the digital transformations of school districts throughout the region.

Hundreds of thousands of Ontario families already rely on Edsby as their primary way to follow class schedules, access class materials, review homework, monitor assessment results, participate in discussions and more. In any given academic year, Ontario teachers use the platform to capture millions of points of learning evidence. This evidence is tagged directly to Ontario curriculum expectations, shared instantly with families and streamlines provincial reporting.

These newest districts join a long and growing list of Ontario boards that have adopted Edsby, including York Region DSB, Greater Essex DSB, Kawartha Pine Ridge DSB, Superior-Greenstone DSB, Nipissing-Parry Sound Catholic DSB, Algoma DSB, St. Clair Catholic DSB, Durham Catholic DSB, Lakehead DSB, Near North DSB and others.

Districts using Edsby repeatedly say the platform has the best capabilities to streamline communications and assessment in the Ontario K-12 environment.

In a profile on Edsby’s website, Kawartha Pine Ridge District School Board calls Edsby the right tool for stakeholder engagement. In a similar profile, Greater Essex County District School Board says the district doesn’t even allow other parent options because “parents know that everything they need–from attendance reporting to grades–is right there in Edsby.”

To learn more about how Edsby is driving K-12 digital transformation in Ontario and beyond, visit www.edsby.com.

About Edsby 

The unique needs of K-12 education are hard to meet with conventional technologies. Edsby’s innovative software systems have been fostering student success and leveraging data responsibly in K-12 worldwide since 2010. Districts, regional governments and independent schools use Edsby for modern K-12 assessment & reporting, family engagement, personalized learning and analytics. Edsby and its products have received more than 90 industry awards and distinctions. Learn more at https://www.edsby.com/.

SOURCE Edsby

Continue Reading

Technology

Ara Partners Acquires Majority Interest in Bryden Wood, a Leading International Integrated Design and Engineering Firm

Published

on

By

BOSTON, Sept. 17, 2026 /PRNewswire/ — Ara Partners, a global private markets firm focused on decarbonising the industrial economy, today announced that it has acquired a majority interest in Bryden Wood, a strategy and integrated design consultancy. Ara will support Bryden Wood’s continued growth and expand the firm’s work across the industrial economy and within Ara’s portfolio.

Bryden Wood brings inventive thinkers, designers, engineers and technical specialists into one team – solving the most complex design problems for some of the largest and most innovative companies in the world. The firm, headquartered in London, UK, employs 300 people in four offices across Europe.

Bryden Wood is changing the way industrial process facilities are designed and delivered. Combining front-end strategic thinking with deep delivery expertise, the company has carved out a distinctive offer turning complex requirements into repeatable, configurable solutions – using reference designs, standardised systems and off-site manufacture.

Across pharmaceuticals, low-carbon industries and data centres, this approach moves projects from strategy to delivery with greater speed and certainty – reducing capital cost, compressing programmes and making facilities easier to replicate at scale.

The transaction, which sees Ara take a majority stake in Bryden Wood, solidifies a multi-year relationship between the companies. Bryden Wood has supported the design evolution and capital strategy for several Ara portfolio decarbonization projects, including Sedron, Divert, Utility Global, BioVeritas, and GIDARA Energy.

“Investment in decarbonisation, data centres and advanced manufacturing is accelerating. The challenge is designing the pathway from promising technologies to physical assets that are investable, buildable and repeatable,” says Bryden Wood co-founder, Martin Wood.

“This partnership with Ara gives us the opportunity to apply our approach at greater scale and make a bigger impact.”

“Bryden Wood has been central to our ability to scale low-carbon process technology and deliver projects on time and on budget,” said Charles Cherington, Co-Founder and Managing Partner of Ara Partners. “We have seen first-hand how their approach takes real capital cost out of major industrial projects, and that advantage compounds across every asset we build. This partnership allows us to deepen that capability within our portfolio and deliver that value to the broader industrial economy.”

About Ara Partners

Founded in 2017, Ara Partners is a global private markets firm focused on decarbonizing the industrial economy. The firm invests in the middle market across three strategies: Private Equity, Infrastructure, and Energy. Ara scales commercially demonstrated decarbonization solutions, supports the businesses and infrastructure that enable their adoption, and reduces emissions at the source across the conventional energy value chain. Ara operates from Houston, Boston, Dublin and Washington D.C., and as of March 31, 2026, had approximately $8.2 billion in assets under management.

For more information about Ara Partners, please visit www.arapartners.com.

About Bryden Wood

Bryden Wood is a strategy and design consultancy that brings together inventive thinkers, designers, engineers, and technical specialists to solve complex challenges in mission-critical infrastructure.

Our 300-person team integrates strategy, design, engineering, and digital expertise to deliver greater quality, speed, and value. Our work is focused on three priorities: accelerating decarbonisation, deploying new technologies, and transforming how infrastructure is designed and delivered.

For 30 years, we have challenged conventional approaches and developed innovative solutions that move industries forward.

Bryden Wood is headquartered in London, with offices in Barcelona, Milan, and Athens.

www.brydenwood.com

Media Contact
Jane Merkler, Ara Partners
jane@arapartners.com 

Media Contact:
Felicity McKane
fmckane@brydenwood.com
+447768828518

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ara-partners-acquires-majority-interest-in-bryden-wood-a-leading-international-integrated-design-and-engineering-firm-302881111.html

SOURCE Ara Partners

Continue Reading

Technology

Dualitas Therapeutics Announces Proximity Biology Research Collaboration with Roche to Discover and Develop Novel Bispecific Antibodies for I&I Diseases

Published

on

By

Dualitas will use its DualScreen™ Bispecific Discovery Engine to functionally screen more than 300,000 novel bispecific combinations for Immunology & Inflammation (I&I) diseases – representing one of the largest-scale bispecific discovery endeavors Collaboration leverages Dualitas’ proximity biology expertise to discover bispecific antibody therapeutics Dualitas to receive $36.5 million in upfront payments and is eligible to receive research, development and commercial milestone payments and tiered royalties for a potential total deal value of up to $1 billion

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 /PRNewswire/ — Dualitas Therapeutics, Inc., a biotechnology company developing next-generation bispecific antibody therapies for immunology and inflammation (“I&I”) indications, today announced a research collaboration and license agreement with Roche to advance novel bispecific antibodies for immunology & inflammation (I&I) diseases, using Dualitas’ DualScreen™ Bispecific Discovery Engine. In what is believed to be one of the largest-scale bispecific discovery endeavors, Dualitas will functionally screen over 300,000 novel bispecific combinations to discover and develop bispecific antibody (“BsAb”) therapeutics. Roche will be responsible for all subsequent preclinical development, regulatory, manufacturing and commercial activities.

The collaboration will leverage Dualitas’ expertise in proximity biology to develop BsAb candidates with synergistic activities that are unattainable with conventional therapeutics. Under the terms of the agreement, Dualitas will receive $36.5 million upfront payment and may receive additional research, development and commercial milestone payments for a potential total deal value of up to $1 billion, in addition to tiered royalties.

“We are thrilled to partner with Roche on this first-of-its-kind collaboration to functionally screen and develop novel proximity BsAbs at a scale that was previously unachievable,” said Forbes Huang, co-founder, chief operating officer and chief business officer of Dualitas. “Since founding Dualitas in 2023, we have established our DualScreen™ discovery engine as the premier technology for discovering next-generation proximity BsAbs, as exemplified by our robust therapeutic pipeline entering clinic next year for I&I diseases.”

“Bispecific antibodies remain central to Roche’s portfolio strategy across many disease areas,” said Boris L. Zaïtra, Head of Corporate Business Development at Roche. “We are committed to continue pushing the boundaries of scientific innovation in immunology and inflammation diseases that will ultimately benefit patients through external partnerships.” 

“This collaboration with Roche underscores the enormous potential of Dualitas’ technologies to identify BsAbs that harness novel proximity mechanisms that may deliver truly differentiated results to patients,” said Karim Dabbagh, Ph.D., CEO and board member of Dualitas. “Our internal pipeline of proximity engager BsAbs has already demonstrated the ability to drive amplified therapeutic effects that push the boundary of what conventional antibody therapies can achieve. This collaboration extends our therapeutic innovations while we continue to develop our internal pipeline.”

DualScreen™ Bispecific Discovery Engine

Dualitas’ first-of-its-kind DualScreen discovery engine uniquely enables high-throughput discovery of proximity biology and novel BsAbs that are rapidly optimized into differentiated drug candidates. Whereas traditional BsAb approaches narrowly focus on pre-determined target pairs to realize incremental gains, the DualScreen™ engine functionally screens entire cell surfaces – interrogating the proximity biology of hundreds of thousands of unique bispecific combinations – across a vast range of targets and epitopes to identify BsAb candidates. DualScreen™ technology has discovered powerful cell surface proximity mechanisms and rapidly delivers drug candidates that achieve synergistic activities unattainable by conventional therapeutics.

About Dualitas Therapeutics

Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody therapies for immunology and inflammation (I&I). Dualitas’ portfolio, built from its DualScreen™ discovery engine, includes development candidate DTX-102 in rheumatoid arthritis, DTX-103 in allergic disease and DTX-101 in dermatologic and gastrointestinal autoimmune disease, alongside additional discoveries based on cell-surface proximity biology and novel co-target pairing. While advancing its own pipeline, Dualitas offers a variety of strategic collaboration opportunities to extend the impact of its discovery capabilities, ranging from existing pipeline programs to identifying de novo BsAbs to establishing programs in disease areas beyond I&I. For more information, please visit https://www.dualitastx.com/ and follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dualitas-therapeutics-announces-proximity-biology-research-collaboration-with-roche-to-discover-and-develop-novel-bispecific-antibodies-for-ii-diseases-302880473.html

SOURCE Dualitas Therapeutics

Continue Reading

Trending